Safety and Efficacy from Recent Clinical Trials for HABP/VABP

Speaker: Marin H. Kollef, MD, FACP, FCCP
Professor, Medicine
Division of Pulmonary and Critical Care Medicine
Washington University

ACPE UAN# 0016-0000-21-004-L01-P, 0.5 contact hour (0.05 CEUs)
0.5 AMA PRA Category 1 Credit(s)™ CME

Learning Objectives

• Describe the key safety and efficacy measures from
  the recent key clinical studies (APEKS-NP, REPROVE,
  ASPECT-NP, RESTORE IMI-2)
• Discuss the role of recently approved antibiotics in
  the treatment of HABP/VABP

Speaker Disclosures:
Dr. Kollef is a consultant for Merck, Pfizer, and Shionogi.